Ingersoll Rand Inc. (IR) raised its full-year 2026 revenue growth outlook to 4.5% to 6.5% after second-quarter sales of $2,049 million, up 9% from a year earlier, with organic growth of 4.1%.

The global provider of mission-critical flow creation and life science and industrial solutions had guided, with its fourth-quarter 2025 results, to full-year revenue growth of 2.5% to 4.5%. The updated range assumes organic growth of +1% to +3%, currency of about +1% and acquisitions of about +2.5%. Adjusted EBITDA guidance of $2,130 million to $2,190 million and Adjusted EPS of $3.45 to $3.57 were reiterated, with Adjusted EPS expected to finish near the high end of the range.

Chairman and Chief Executive Officer Vicente Reynal said the quarter reflected strong organic growth and solid Adjusted EPS performance, and that order momentum continues to build. Reported net income attributable to Ingersoll Rand was $257 million, or $0.66 a share, versus a $115 million loss, or $0.29 a share, a year earlier. Adjusted net income attributable to the company was $339 million, or $0.86 a share, up 7%. Adjusted EBITDA was $520 million, with a margin of 25.4%, down from 27.0% a year earlier.

The turn in the larger Industrial Technologies and Services segment was the quarter’s inflection. IT&S reported orders of $1,621 million, up 4%, or approximately flat organically, after first-quarter organic orders were down 3%. Revenues were $1,622 million, up 9%, or up 4% organically, after first-quarter organic revenue was down 2%. Segment Adjusted EBITDA was $435 million, with a margin of 26.8%, down 180 basis points year over year. IT&S saw positive organic revenue growth in all regions, with a book-to-bill of 1.0x. Organic order growth was flat, with healthy compressor activity, particularly in North America, offset by the timing of long-cycle project orders in the blower and vacuum business in Europe, as well as the ongoing impact from the Middle East. Overall compressor orders were up low single digits globally. Adjusted EBITDA margin was down year over year, driven largely by challenges in offsetting inflationary impacts with price, primarily in China, as well as continued commercial investments for growth.

Precision and Science Technologies accelerated. P&ST reported orders of $422 million, up 11%, or up 7% organically, after first-quarter organic orders were up 1%. Revenues were $427 million, up 8%, or up 4% organically. Segment Adjusted EBITDA was $135 million, up 15%, with a margin of 31.5%, up 200 basis points year over year. P&ST saw strong demand, with organic orders up 7%, including low double-digit growth in Life Sciences and mid single-digit growth in Precision Technologies. Adjusted EBITDA margin finished at 31.5%, up 200 basis points year over year, driven by strong operational execution fueled by IRX.

Reported orders were $2,043 million, up 5% year over year, with organic order growth of 1.6%. Free cash flow was $269 million, up from $210 million a year earlier, with a free cash flow margin of 13.1%. Liquidity was $3.8 billion as of June 30, 2026, including $1.2 billion of cash on hand and undrawn capacity of $2.6 billion under available credit facilities. Net debt to Adjusted EBITDA leverage was 1.7x. In June 2026, Moody’s upgraded the company one notch to Baa1.

In the second quarter, the company deployed $110 million to M&A, including for the previously announced acquisition of Fox s.r.l., and returned approximately $248 million to shareholders through $240 million in share repurchases and $8 million through its quarterly dividend payment. Ingersoll Rand announced the signing of the acquisition of Fai Filtri s.r.l., a leading manufacturer of high-performance industrial filters, expected to close in the fourth quarter of 2026. The company also expects to close on the acquisition of a U.S.-based blower manufacturer on July 31, 2026.